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During the nosocomials infections occurring in the intensive care unit of the military hospital of Tunis 
in 2005, the Enterobacter cloacae BW 1150 strain was isolated from a stool culture. This strain was 
found to have a high level resistance to broad-spectrum -lactams. Resistance profile against the 
various families of antibiotics was determined using the disc diffusion test. The minimal inhibitory 
concentrations values showed that this strain was resistant to the -lactams such as ampicillin and the 
extended spectrum cephalosporins (cefotaxime, ceftriaxon and cefpirome). Analysis of this strain by 
the disk diffusion test revealed synergies between amoxicillin-clavulanate (AMX-CA) and ceftriaxon, 
ceftazidime and cefotaxime. Cell sonicate of this isolate is very active against cefotaxime and showed a 
specific activity (AS) of 7.54 U/mg for the same antibiotic. This activity was inhibited by the sulbactam 
and the clavulanic acid. Isoelectrofocusing methods revealed that the crude extract of the E. cloacae 
BW 1150 strain showed 1 - lactamase activity with an isoelectric piont (pI) of about 8. This activity was 
transferred by conjugation and was highly expressed in the transconjugant. 
 





Enterobacter species are a common cause of several 
human diseases and are predominantly associated with 
nosocomial infections. They are responsible for 5% of all 
nosocomial septicaemia cases in the United States and 
can be found as the third most common pathogens 
recovered from the respiratory tracts of patients in 
intensive care units (Stock et al., 2001). Among the 
variety of Enterobacter species, E. cloacae is a well-
reconized nosocomial pathogen that causes significant 
infections, especially in last recent years (Conceição et 
al., 2004). This microorganism is the most commonly 
isolated member of the Enterobacteriaceae that possess 
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an important role in resistance to antibiotics (Bell et al., 
2003). However, several reports have demonstrated that 
this species can acquire and express genes encoding 
extended spectrum -lactamase (ESBLs), especially for 
the multidrug isolates (Hall et al., 2006). In fact, it has 
been reported that the wild-type strains of E. cloacae can 
express the bush group 2f carbapenemases Nmc-A, VIM-
2, IMI-2 and VIM-4  (Pottumarthy et al., 2003; Jeong et 
al., 2003 ; Yu et al., 2006 ; Luzzaro al., 2004). The 
resistance to broad-spectrum penicillins and extended-
spectrum cephalosporins via the acquisition of plasmids 
encoding TEM and SHV derivatives BLSEs has also 
been reported (Liu et al., 2004). Various extended-spec-
trum -lactamases not derived from TEM or SHV enzy-
mes have been described in this species, such as SFO 
type in Japan (Matsumoto et al., 1999 ), IBC-1 type in 
Greece (Giakkoupi et al., 2000), VEB-3 type in Thailand 






cribed more recently (Doucet et al.,  2000 ; Chanawong 
et al.,  2002; Kim et al. , 2005; Touati et al. , 2006). 
In this work, we report the biochimical analysis of 
cefotaximase producing clinical isolate of E. cloacae from 
the military hospital of Tunis. 
 
 
MATERIALS AND METHODS 
 
Bacterial strains  
 
One isolate of E. cloacae BW 1150 is included in this study. This 
strain was isolated from a stool culture in intensive care unit of the 
military hospital of Tunis in 2005. This isolate was identified using 
the API 20 E identification system (bioMérieux, Marcy l’Etoile, 
France). E. coli HB101 (F-, ∆(gpt-proA) 62, leuB6, supE44, ara-14, 
galK2, lac Y1, ∆(mcrc-mrr), rps, L26, Xyl-rmtl 1, thi-1, IncFI, rec AB, 
strr) is resistant to strptomycin and is used for the cojugaison 
experiences.    
 
 
Susceptibility testing and extended-spectrum -lactamase 
detection 
 
The antibiotics susceptibilities of the E. cloacae BW 1150  strain 
was determined on Muelluer-Hinton agar by the standard disk 
diffusion procedure as described by the antibiogram committee of 
the French society for microbiology (www.sfm.asso.fr) (Cavallo et 
al., 2007). The following antibiotics were tested, ampicillin, 
ticarcillin, cefoxitin, cefotaxime, ceftazidime, ceftriaxone, cefpirome, 
streptomycin, ciproflaxacine, aztrenam, imipinem, tetracycline, 
cloramphenicol, acid nalidixique (Biorad, Marnes-la-Coquette, 
France). 
The ESBL detection was based on the double-disk synergy test 
(DDST) as described previously (Ben et al., 2007). DDST was 
performed as follows: the surface of a Muelleur-Hinton (MH) agar 
plate was inoculated with an overnight culture suspension of clinical 
isolate. After inoculation, disks containing 30 µg of ceftazidime, 
cefotaxime, ceftriaxone, cefpirome and amoxicillin-clavulanic acid 
(20/10 µg) were placed at distances of 20 mm (center to centre). 
Enhancement of the inhibition zone between the disks containing 
clavulanic acid and cefotaxime, ceftriaxone, ceftazidime or 
cefpirome indicated the presence of ESBL produc-tion. 
 
 
Determination of minimum inhibitory concentration 
 
Minimum inhibitory antibiotics concentrations were determined by 
the serial dilution method. The minimum inhibitory concentration 
results were interpreted according to the recommendations of the 
antibiogram committee of the French society for microbiology 
(ACFSM) (Cavallo et al., 2007). 
 
 
Preparation of crude enzyme extracts 
 
Bacterial strain was grown overnight with shaking in 50 ml of 
tryticase soy broth (TSB) (Diagnostics, Pasteur, France) at 37°C. 
The cells were harvested by centrifugation and washed once in 25 
mM potassium-sodium phosphate buffer (pH 7) and resuspended in 
1 ml of the same buffer. 
For preparation of cell-free extract, the cells were ruptured by 
ultrasonic treatement in a UP 400 S sonicator at 4°C. Cell debris 
was removed by centrifugation at 10000 rpm for 10 min in a hettich 
centrifuge R 32 rotor. The supernatant was used for all  -lactamas-
ses enzyme tests (Ben et al., 2007). 






-Lactamase activities were determined by spectrophotometric 
method of O’calloghan et al. (1975). Briefly, the decrease in 
absorbance of the antibiotics at an appropriate concentration and 
wavelength was measured in a temperature controlled spectro-




Inhibitors effects (IC50 determination) 
 
For determination of inhibitor effects, rates of hydrolysis of 1 mM 
cephalotin were determined in the presence of various concen-
trations of clavulanic acid and sulbactam. EDTA (Ethylenediamine 
tetraacetic acid) was used for 1 mM as concentration. In these 
experiments the proteic extract was preincubated with the inhibitors 
for 10 min before the addition of cephalotin. The inhibitory concen-
tration that allowed the reduction of -lactamases activities of 50% 
was determined from the curve: AS = f (inhibitors concentration) 
(Réjiba et al., 2002). 
 
 
Conjugation and resistance transfer  
 
Conjugation experiment using Escherichia coli HB101 strR as the 
recipient strain was performed. Transconjugants were selected on 
Miller-Hinton agar plates containing streptomycin (20 µg/ml), 
ticarcillin (2 µg/ml) and cefotaxime (2 µg/ml). To select the plasmid-
encoded resistance, the transjugants growing on the selection 
plates were subjected to DDST to confirm the presence of ESBL 
(Ben-Hammouda et al., 2004). 
 
 
Analytical isoelectric focusing (IEF) 
 
IEF was performed as follows, bacterium growing exponentially at 
37°C in tryticase soy broth was harvevested at 10000 rpm for 10 
min (Beckman centrifuge, FO650 Rotor) and cell-free lysate was 
prepared by sonication (sonicator UP 400S cycle: 25 and amplitude 
50 Hz). Crude sonic extract was centrifuged at 10000 rpm for 10 
min and the supernatant was collected and subjected to IEF in 
broad range (Ph 3 - 10) polyacrylamide gel 7% at 4°C. The ß-lacta-
mase activity was detected by the iodine procedure in gel by using 





Ssusceptibility testing and extended-spectrum -
lactamase detection 
 
Antibiotics susceptibility testing revealed that this isolate 
was resistant to all penicillins and cephalosporins tested 
except ceftazidime. For its resistance to others antibio-
tics, this strain was resistant to cloramphenicol, tetracy-
cline, nalidixic acid. Whereas, this isolate remain suscep-
tible to imipinem and streptomycin (Table 1). The enhan-
cement of the inhibition zone between the disks contain-
ing amoxicillin-clavulanate and cefotaxime, ceftriaxone 
and cefpirome indicated the presence of ESBL produc-
tion (data not shown).  
 
 
Minimal inhibitory concentration 
 
The resistance to -lactams of E. cloacae BW 1150 strain 
  




Table 1.  Antibiotics susceptibility of the E. cloacae BW 1150 strain, transconjugant and E. coli recipient. 
 
Antibiotic E. cloacae BW 1150 E. coli HB 101 x E. cloacae BW 1150 E. coli HB 101 
Ceftazidime 22 20 25 
Cefotaxime 12 14 26 
Cefpirome 13 14 26 
Ceftreaxone 14 14 23 
Streptomycin 27 14 14 
Ciproflaxacin 15 13 28 
Ticarcillin 6 6 25 
Nalidixic acid 8 6 30 
Ampicillin 6 6 32 
Aztreonam 18 16 35 
Cefoxitim 6 28 32 
Cloramphenicol 6 24 34 
Tetracyclin 6 24 29 






Table 2.  MIC values (g/ml) of the E. cloacae BW 1150 strain, transconjugant and E. coli recipient. 
 
Antibiotic E. cloacae BW 1150 E. coli HB101xE. cloacae  BW 1150 E. coli HB 101 
Ceftazidime 8 4 <1 
Céfotaxime >512 >512 1 
Cefpirome >512 >512 2 
Ceftreaxone >512 >512 <1 
Streptomycin 4 >256 >256 
Ciproflaxacin >512 >256 2 
Ticarcillin >512 >256 2 
Nalidixic acid 512 >256 1 
Ampicillin >512 >256 4 
Aztreonam 128 128 4 
Cefoxitim 512 4 2 
Cloramphénicol 256 4 <1 
Tetracyclin 512 2 2 






is confirmed by the Minimal inhibitory concentration of the 
penicillins (ampicillin and ticarcillin), the extended spec-
trum cephalosporins (cefoxitin, cefotaxime, ceftriaxon, 
cefpirom except ceftazidime) which exceed 256 µg/ml. 
This strain is also resistant to others antibiotic, in addition 
to the - lactams. Indeed, this strain is highly resistant to 
cloramphenicol, tetracyclin and quinolones (Nalidixic 
acid) with a value that exceed 256 µg/ml. Nevertheless, it 
remains sensitive to imipinem and streptomycin (Table 
2). 
-Lactamase essay and inhibitor susceptibility 
 
Analysis of the crude extract by the startch, 7% polyacry-
lamide gel electrophoresis revealed one band in the pre-
sence of benzylpenicillin; the same band was visualized 
with cefotaxime (Figure 1). 
E. cloacae BW 1150 hydrolyzed oxyimino-cephalo-
sporins in addition to benzylpenicilline and ticarcillin. 
Cefotaxime was the most stable among the cephalo-








Figure 1. Activity -lactamase detection of 
the E.cloacae BW 1150 strain after native 
electrophoresis 7.5% in the presence of 1 
mM benzylpenicillin (A) and 3 mM cefo-




Table 3. -Lactamases specific activity (µmole of 
substrat/minut/mg of protein) produced by E. cloacae BW 
1150. 
 














aztreonam by E. cloacae BW 1150 was not detectable 
(Table 3). E. cloacae BW 1150 activity was inhibited by 
clavulanic acid and sulbactam  but  was  not  inhibited  by 
EDTA (Table 4). These characteristics resembled those 




Conjugation and resistance transfer  
 
Conjugation from E. cloacae BW 1150 to E. coli HB 101 
was   successful.   Only    the    resistance   to   ampicillin,  






Figure 2. Isoelectric focusing of E.cloacae 
BW 1150 and its transconjugants. Lane 1, 
Markers; lane 2, E. cloacae BW 1150; lane 3, 




ticarcillin, cefotaxime and cefpirome was transferred, 
suggesting that the genes of resistance to these anti-
biotics are on a conjugable R plasmid (Table 1). This 
resistance is confirmed by the minimal inhibitory concen-
tration (Table 2). The enhancement of the inhibition zone 
between the disks containing clavulanic acid and cefo-
taxime and cefpirome indicated the presence of ESBL 
production (data not schown). 
 
 
Analytical isoelectric focusing (IEF) 
 
The supernatants of E. cloacae BW 1150 and the trans-
conjugant were collected and subjected to IEF in broad 
range (pH 3 - 10) polyacrylamide gel 7% at 4°C. The -
lactamase activity was detected according to the iodo-
metric method in the presence of the benzylpenicillin as 
substrate. The E. cloacae BW 1150 and its transcon-
jugant produce the same -lactamase activity with a pI of 





The clinical isolate of E. cloacae BW 1150 included in this 
study was isolated in the intensive care unit at the military 
hospital in Tunisia in 2005. This isolate showed a multi-
drug resistance phenotype including resistance to the 
extended spectrum -lactams except the ceftazidime, 
cloramphenicol, tetracyclin and quinolone (Nalidixic acid). 
Whereas, this isolate was found susceptible  to  imipinem  
  




Table 4. Inhibitor effects on -lactamase activity produced by E. cloacae BW 
1150. 
 
Organism (IC50 µM) 
Clavulanic acid Sulbactam EDTA 
E. cloacae BW 1150 0.76 1.34 - 
 




the ICM of various antibiotics was determined, which 
showed a high level of resistance for this isolate. The 
double disk synergy gave a positive result for this isolate, 
suggesting the presence of extended spectrum- -lacta-
mase. This activity was strongly active against cefota-
xime and it was inhibited by the clavulanic acid which 
confirm that it belong to serine active -lactamase. Con-
jugation experiment using E. coli HB 101 SR as the 
recipient strain was performed. Penicillines and cephalo-
sporines resistance was transferred by conjugation. Iso-
electric focusing analysis of the supernatant of E. cloacae 
BW 1150 and its transconjugant showed 1 band with pI of 
about 8. This result showed that this enzyme is on a con-
jugable plasmid. According to the -lactam susceptibility 
profile, the specific activity and the isoelectric point, this 
enzyme seems to have resemblances with other CTX-M-
type -lactamases (Bonnet et al., 2004). Indeed, this -
lactamase hydrolize all ampicillins and cephalosporins 
with a high hydrolytic activity to cefotaxime. Furthermore, 
the specific activity of this isolate was restored in the pre-
sence of inhibitors. Considering its isoelectric point, the -
lactamase of pI of about 8 is similar to CTX-M-9 pre-
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